HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two-Step transplant aims to boost survival in tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant method for patients with high-risk blood cancers like leukemia and lymphoma. It used a drug called cyclophosphamide before the transplant to help prevent a dangerous complication called graft-versus-host disease. The goal was to i…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New transplant strategy aims to save more lives by taming dangerous side effects
Disease control CompletedThis study tested if giving the drug cyclophosphamide *after* a stem cell transplant, instead of before, could make transplants safer and more effective for people with blood cancers. It focused on patients who needed a transplant but did not have a perfectly matched sibling dono…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for Tough-to-Treat blood cancers: Two-Drug combo shows promise
Disease control CompletedThis study tested a new combination of two immunotherapy drugs (pembrolizumab and vibostolimab) for people with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to check the safety of the treatment and see how well it worked …
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New scan could spare patients from long, toxic treatments
Diagnosis CompletedThis study aimed to see if a special type of PET scan could help doctors better manage a serious fungal infection called hepatosplenic candidiasis. The infection mainly affects the liver and spleen of cancer patients with weakened immune systems. Researchers tested if the scan co…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
Early cancer drug study focuses on how genetics affect medication processing
Knowledge-focused CompletedThis early-phase study examined how the cancer drug belinostat is processed by the body in patients with advanced solid tumors or blood cancers that have returned or stopped responding to treatment. Researchers specifically looked at how different genetic variations affect drug p…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC
-
A multicenter, randomized, phase III registration trial of transplantation of NiCord®, ex vivo expanded, UCB-derived, stem and progenitor cells, vs. unmanipulated UCB for patients with hematological malignancies
CompletedThis study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, m…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE3 • Sponsor: Gamida Cell ltd
Last updated Mar 02, 2026 15:25 UTC